The Greater Cannabis Company, Inc. (GCAN)
|Net Income (ttm)||-1.66M|
|Trading Day||January 15|
|Day's Range||0.0048 - 0.0115|
|52-Week Range||0.0018 - 0.0371|
There are no news available yet.
The Greater Cannabis Company, a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. The company intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies in the legal cannabis and CBD industries to bring the product to the North American market in legal medical and recreational cannabis and CBD segments. The Greate... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
In 2019, GCAN's revenue was $7,120, a decrease of -92.53% compared to the previous year's $95,375. Losses were -$1.65 million, 96.5% more than in 2018.